Market Whales and Their Recent Bets on VKTX Options
Market Whales and Their Recent Bets on VKTX Options
From the overall spotted trades, 4 are puts, for a total amount of $146,590 and 10, calls, for a total amount of $1,709,969.Whales with a lot of money to spend have taken a noticeably bullish stance on Viking Therapeutics.
擁有大量資金的鯨魚在維京療法方面採取了明顯的看好態度。
Looking at options history for Viking Therapeutics (NASDAQ:VKTX) we detected 14 trades.
查看維京生物公司（納斯達克：VKTX）期權歷史，我們檢測到14筆交易。
If we consider the specifics of each trade, it is accurate to state that 71% of the investors opened trades with bullish expectations and 21% with bearish.
如果我們考慮每筆交易的具體情況，準確地說，71%的投資者開出看好交易，21%爲看跌交易。
From the overall spotted trades, 4 are puts, for a total amount of $146,590 and 10, calls, for a total amount of $1,709,969.
在所有發現的交易中，有4筆看跌交易，總金額爲$146,590，以及10筆看漲交易，總金額爲$1,709,969。
What's The Price Target?
目標價是多少？
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $35.0 to $100.0 for Viking Therapeutics during the past quarter.
分析這些合約中的成交量和未平倉量，似乎大戶們一直在關注維京生物公司的股價區間爲$35.0至$100.0。
Analyzing Volume & Open Interest
分析成交量和未平倉合約
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Viking Therapeutics's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Viking Therapeutics's significant trades, within a strike price range of $35.0 to $100.0, over the past month.
審查成交量和未平倉量對股票研究提供了關鍵見解。這些信息對衡量維京生物公司在特定行權價的期權的流動性和興趣水平至關重要。下面我們展示了過去一個月內維京生物公司重要交易（在$35.0至$100.0行權價範圍內）的看漲和看跌成交量和未平倉量趨勢的快照。
Viking Therapeutics Call and Put Volume: 30-Day Overview
維京治療公司看漲和看跌期權的成交量：30天概述
Noteworthy Options Activity:
值得注意的期權活動：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | CALL | TRADE | BEARISH | 01/17/25 | $4.3 | $3.8 | $3.9 | $90.00 | $1.0M | 1.2K | 3.2K |
| VKTX | CALL | SWEEP | BULLISH | 11/15/24 | $10.2 | $9.9 | $10.2 | $60.00 | $203.9K | 6.0K | 206 |
| VKTX | CALL | SWEEP | BEARISH | 01/17/25 | $4.1 | $4.0 | $4.1 | $90.00 | $106.6K | 1.2K | 333 |
| VKTX | CALL | SWEEP | BULLISH | 12/20/24 | $10.3 | $10.0 | $10.3 | $62.50 | $102.9K | 0 | 101 |
| VKTX | CALL | TRADE | BULLISH | 11/15/24 | $5.4 | $5.1 | $5.3 | $70.00 | $53.0K | 8.4K | 407 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| VKTX | 看漲 | 交易 | 看淡 | 01/17/25 | $4.3 | $3.8 | $3.9 | $90.00 | $1.0M | 1.2K | 3.2K |
| VKTX | 看漲 | SWEEP | 看好 | 11/15/24 | $10.2 | $9.9 | $10.2 | $60.00 | $203.9K | 6.0K | 206 |
| VKTX | 看漲 | SWEEP | 看淡 | 01/17/25 | $4.1 | $4.0 | $4.1 | $90.00 | $106.6K | 1.2K | 333 |
| VKTX | 看漲 | SWEEP | 看好 | 12/20/24 | $10.3 | $10.0 | $10.3 | $62.50 | $102.9K | 0 | 101 |
| VKTX | 看漲 | 交易 | 看好 | 11/15/24 | $5.4 | $5.1 | $5.3 | 70.00美元 | 53.0千美元 | 8.4K | 407 |
About Viking Therapeutics
關於Viking Therapeutics
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.
Viking Therapeutics Inc是一家衛生服務提供商，專門從事代謝和內分泌障礙領域的生物製藥開發。該公司的臨床項目流水線包括VK2809、VK5211、VK0214產品。VK2809和VK0214是口服、組織和受體亞型選擇性的甲狀腺激素受體β激動劑。VK5211是一種口服、非類固醇選擇性雄激素受體調節劑。
In light of the recent options history for Viking Therapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鑑於維京療法的最近期權歷史，現在着眼於該公司本身是合適的。我們的目標是探討其當前表現。
Current Position of Viking Therapeutics
維京療法的當前位置
- Trading volume stands at 1,053,499, with VKTX's price down by -3.4%, positioned at $62.15.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 1 days.
- 成交量爲1,053,499，VKTX的價格下跌了-3.4%，定位在$62.15。
- RSI指標顯示該股票目前處於超買和超賣之間的中立狀態。
- 預計1天內發佈盈利聲明。
Professional Analyst Ratings for Viking Therapeutics
Viking Therapeutics的專業分析師評級
In the last month, 2 experts released ratings on this stock with an average target price of $114.0.
在過去一個月裏，有2位專家發佈了對這隻股票的評級，平均目標價爲114.0美元。
Unusual Options Activity Detected: Smart Money on the Move
檢測到期權異動：智慧資金在行動。
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.* In a cautious move, an analyst from Oppenheimer downgraded its rating to Outperform, setting a price target of $138. * In a cautious move, an analyst from HC Wainwright & Co. downgraded its rating to Buy, setting a price target of $90.
Benzinga Edge的期權異動板塊會在事件發生前發現潛在的市場變動，看看大額資金在您喜愛的股票上的持倉。點擊這裏進行訪問。* 以謹慎的舉措，Oppenheimer的分析師將評級調降至外表現，設定目標價爲138美元。* 以謹慎的舉措，HC Wainwright & Co.的分析師將評級調降至買入，設定目標價爲90美元。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。
